In situ hybridisation (ISH), using methods such as RNAscope®, is a popular approach for the evaluation of changes in biomarker expression or a particular drug response effect in tissues, especially in the case of novel biomarkers where robust, well validated antibodies are not commercially available. We have extensive experience in the quantification of RNA expression on a cell by cell basis across a whole tissue section or within defined regions of interest.
Benefits of OracleBio’s ISH & RNAScope Services:
- Reliable Data – Our attention to detail and experience with forming cell objects means we are able to accurately quantify transcription levels
- Complete Transparency – We provide a secure web portal, allowing you to view all your images and analysis in real time
Learn More About Our Advanced Immuno-Oncology Services
OracleBio's Quantitative Image Analysis Workflow
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more